.@US_FDA fast-tracks Leap’s gastric #cancer immunotherapy https://teapawt.net/t.co/u6H5ONN4h0 #regulatory
Trump’s vaccine ‘October surprise’ in doubt as @US_FDA toughens standards https://teapawt.net/t.co/6ZHZB8RcdB #regulatory
.@NICEComms relents and okays Akcea’s rare disease #drug Waylivra for #NHS use https://teapawt.net/t.co/JUb4FVjxED #regulatory
.@US_FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) https://teapawt.net/t.co/8bVCFDLgsG #regulatory
Senior @US_FDA officials say decision on COVID-19 vaccine will be guided by science https://teapawt.net/t.co/Hpd8bPyC89 #regulatory
ImmuPharma updates on US FDA Special Protocol Assessment submission for Lupuzor's Phase III trial https://teapawt.net/t.co/DkLdlcb02j #regulatory
Imfinzi approved in #EU to treat extensive-stage small cell lung cancer https://teapawt.net/t.co/o5K8wKyYdv #regulatory
.@JanssenUS files for @US_FDA approval of Darzalex Faspro https://teapawt.net/t.co/XAXr3rp6dJ #regulatory
.@Roche, Blueprint Medicines' Gavreto approved in US for RET fusion-positive lung cancer https://teapawt.net/t.co/aytUhUSgGU #regulatory
.@US_FDA approves @Roche Gavreto to treat non-small cell lung #cancer https://teapawt.net/t.co/9bFXXvKLb0 #regulatory
.@bmsnews bags US approval for Onureg https://teapawt.net/t.co/dBkfppHRLN #regulatory
Janssen disappointed with second @NICEComms no for Spravato https://teapawt.net/t.co/WPzypCLi8P #regulatory
.@EMA_News begins review of Dexamethasone Taw for #COVID19 https://teapawt.net/t.co/EQ1y0pFMQj #regulatory
Improving @US_FDA #COVID19 vaccine authorization and approval process https://teapawt.net/t.co/PSoKONmulY #regulatory
.@US_FDA releases PDUFA VI program report on combination products https://teapawt.net/t.co/8WjpL1JwEx #regulatory
.@Roche gets @US_FDA approval for 'FoundationOne Liquid CDx' test https://teapawt.net/t.co/7HdLadcFxT #regulatory
Industry group says @US_FDA botched #COVID19 convalescent plasma guidance https://teapawt.net/t.co/ND7RO3H3wo #regulatory
.@US_FDA hands Cassiopea its first approval, for acne #drug Winlevi https://teapawt.net/t.co/h5WridA9Ze #regulatory
US regulators have issued a green light for a Phase III clinical trial testing EUSA Pharma's for patients seriously ill with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). https://teapawt.net/t.co/M528HwY7NN
